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Endovascular treatment (EVT) has been proven effective in patients with acute ischemic stroke (AIS) because of 
an intracranial large vessel occlusion (LVO) of the anterior 
circulation.1 The effect of EVT is highly time-dependent and 
a reduction in onset-to-treatment time increases the chance of 
good functional outcome for the patient.2,3
Studies focusing on workflow characteristics identified 
interhospital transfer as one of the main causes of treatment 
delay in the recent randomized controlled trials.4,5 Patients 
with AIS are often first presented at the nearest primary stroke 
center to provide rapid treatment with intravenous thrombo-
lytics (IVT). If the diagnostic workup indicates eligibility for 
EVT, the patient is then transferred to an intervention center 
with facilities for EVT (drip-and-ship). Analysis of data 
from a US registry suggested that this drip-and-ship method 
increases time to treatment and decreases the odds of good 
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functional outcome in daily clinical practice.6 However, the 
effect of inter-hospital transfer might be different in a more 
densely populated region with short between-center distances 
and a well-organized acute stroke care system.
We investigated the frequency of interhospital transfer and 
the characteristics of transferred patients in a large nationwide 
cohort in the Netherlands: MR CLEAN Registry (Multicenter 
Randomized Clinical Trial of Endovascular Treatment for 
Acute Ischemic Stroke in the Netherlands). We aimed to 
assess the effect of interhospital transfer on time to treatment 
and functional outcome in routine clinical practice.
Methods
Study Design
Detailed methods of the MR-CLEAN Registry have been reported 
previously.7 The MR-CLEAN Registry is an ongoing, prospective, ob-
servational study in all centers that perform EVT in the Netherlands. 
Registration started in March 2014, directly after the final inclusion 
in MR-CLEAN. All 18 intervention centers in the Netherlands, of 
which 16 centers participated in the MR-CLEAN trial, registered their 
patients. All data were centrally collected and checked for complete-
ness and consistency. The imaging assessment committee assessed im-
aging and the adverse event committee scored the safety parameters.
The central medical ethics committee of the Erasmus MC 
University Medical Center, Rotterdam, the Netherlands, evaluated 
the study protocol and granted permission to perform the study as 
a registry. Data will not be made available to other researchers as no 
patient approval has been obtained for sharing coded data. However, 
syntax and output files of statistical analyses are available from the 
corresponding author on reasonable request.
Study Population
All consecutive patients with AIS in the anterior and posterior cir-
culation who received arterial groin puncture in the angiosuite have 
been registered. For the current analysis, we used data of patients 
treated between March 2014 to June 2016. We included patients 
adhering to the following criteria: age ≥18 years; treatment in a center 
that participated in the MR-CLEAN trial; and presence of an intracra-
nial proximal arterial occlusion in the anterior circulation (intracra-
nial carotid artery [ICA/ICA-T], middle cerebral artery [M1/M2] or 
anterior cerebral artery [A1/A2]), demonstrated by computed tomog-
raphy (CT) angiography. EVT could consist of arterial catheterization 
followed by mechanical thrombectomy and thrombus aspiration, with 
or without delivery of a thrombolytic agent. Patients arrived either 
directly at the intervention center or were transferred from one of the 
primary stroke centers (Figure 1). Emergency Medical Services in 
the Netherlands identify potential stroke patients using the face, arm, 
speech test, and transport patients with an onset time of <6 hours to 
the closest stroke center with IVT and EVT facilities.
Definitions and Outcome Measures
Time of stroke onset was defined as the moment of witnessed 
onset of stroke symptoms or, when exact onset was unknown, the 
moment that the patient was last seen well. Admission outside 
office hours was defined as time of arrival at the intervention center 
on working days between 5 pm and 8 am, during weekend days or na-
tional festive days. All transfer patients received a noncontrast CT 
in the primary stroke center, and most transfer patients received a 
CT-angiography before transfer to an intervention center. Imaging 
was not routinely repeated on arrival at the intervention center, but 
only in case of a clinical indication (eg, deterioration or substan-
tial improvement). Imaging characteristics were assessed based on 
the first scan made (for transferred patients in the primary stroke 
center, for direct patients in the intervention center). Transfer-
related travel time between each primary stroke center and the 
receiving intervention center was estimated using the TomTom 
MyDrive application (version 4.2.1.3495, available on https://
mydrive.tomtom.com). A ratio of 0.85 was subsequently applied 
on each calculated time to approach the transfer-related travel 
time that an ambulance would actually need. This ratio is based 
on measured travel times of ambulances in a previous study in 
the Netherlands.8 The door in door out time in the primary stroke 
center was then estimated by subtracting the transfer-related travel 
time from the reported time from door of the primary stroke center 
to door of the intervention center.
Primary outcome was the time from first presentation to start of 
treatment, defined as the interval between arrival at the first hospital 
to arterial groin puncture. Secondary outcomes included: time from 
arrival at intervention center to groin puncture; time from stroke onset 
to groin puncture; the modified Rankin Scale (mRS) at 90 days after 
stroke; functional independence, defined as mRS score of 0–2; mor-
tality at 90 days; successful reperfusion at the end of EVT, defined 
as an extended Thrombolysis in Cerebral Infarction score ≥2B9; and 
occurrence of symptomatic intracranial hemorrhage. Intracranial 
hemorrhage was defined as symptomatic if patients died or deterio-
rated neurologically (an increase of ≥4 points on National Institutes 
of Health Stroke Scale [NIHSS] score compared with NIHSS before 
worsening), and the hemorrhage was related to the clinical deteriora-
tion (according to the Heidelberg Bleeding Classification).10
Statistical Analysis
We compared patients transferred from a primary stroke center 
with patients who were directly admitted to an intervention center. 
Baseline characteristics were compared using χ2 test for categorical 
variables, independent samples t test for normally distributed con-
tinuous variables, and Mann-Whitney U test for nonnormal distrib-
uted continuous variables. Time intervals were expressed as medians 
with interquartile range. For regression analyses, missing data were 
imputed using multiple imputations by chained equations based on 
relevant covariates and outcome.
Linear regression analyses were used to assess the effect of 
transfer on time intervals. Prespecified adjustments were made for 
age, baseline NIHSS score, prestroke mRS score, treatment with IVT, 
hypertension (baseline systolic blood pressure >185 mm Hg and di-
astolic blood pressure >110 mm Hg), location of occlusion, Alberta 
Stroke Program Early CT Score on noncontrast CT, collateral score 
on CT angiography, the use of general anesthesia, and admission out-
side office hours. The effect of transfer on functional outcome was 
assessed using an ordinal logistic regression analysis for the shift in 
mRS score at 90 days. Binary logistic regression analyses were used 
for functional independence, mortality, successful reperfusion, and 
occurrence of symptomatic intracranial hemorrhage. These analyses 
were adjusted for the following prespecified variables: age, baseline 
NIHSS score, prestroke mRS score, history of ischemic stroke or 
transient ischemic attack, treatment with IVT, location of occlusion, 
Alberta Stroke Program Early CT Score, collateral score, and time 
from onset to first hospital.
All analyses were performed using R software (Version 3.4.4, R 
Foundation) with the rms package (version 5.1-2).
Results
In total, 1627 consecutive patients treated with EVT for AIS 
were included in the MR-CLEAN Registry between March 
2014 and June 2016. We excluded 101 patients for the fol-
lowing reasons: age below 18 years (n=2); EVT performed in 
a non-MR-CLEAN center (n=20) and occlusion of the pos-
terior circulation (n=79). The remaining 1526 patients were 
included in the analyses (Figure 2). Of these patients, 821 
(53.8%) were transferred from a primary stroke center, and 
705 (46.2%) were presented directly to an intervention center. 
The percentage of transferred patients ranged between 3.4% 
and 77% per intervention center.
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Baseline Characteristics
Demographics and baseline stroke severity were similar in 
both groups: median age was 71 years for transferred patients 
versus 70 years for directly admitted patients; 53% of all 
patients were men, and median NIHSS at baseline was 16 
for both groups (Table 1). Transferred patients were more 
often treated with IVT (80.5% versus 72.6%; P<0.01) and 
had less often prestroke disability (mRS≥1, 28.4% versus 
36.5%; P=0.02). Imaging characteristics were less favorable 
for transferred patients, with lower Alberta Stroke Program 
Early CT Score (median 8 versus 9; P=0.01) and more often 
absent or poor collaterals (collateral score 0–1, 44.1% versus 
35.2%; P<0.01). Transferred patients less often had an occlu-
sion of segment 2 of the middle cerebral artery (10.6% versus 
14.4%; P=0.01). Imaging was repeated in 49/821 (6%) and 
39/821 transfer patients (4.8%]) for noncontrast CT and 
CT-angiography, respectively.
Treatment Times
The median time from arrival at the first hospital to 
groin puncture was longer for transferred patients than 
for patients who were directly admitted to an interven-
tion center (164 versus 104 minutes; P<0.01, Table 2). 
The adjusted difference was 57 minutes (95% CI, 51–62 
minutes), in favor of patients who were admitted directly 
(Tables 3 and 4). After subtraction of the mean estimated 
transfer-related travel time (23 minutes), this time differ-
ence was 39 minutes. Transferred patients arrived slightly 
earlier after stroke onset at the first hospital (50 versus 55 
minutes; P<0.01), but time from onset to arrival at the in-
tervention center was much longer (174 versus 55 minutes; 
P<0.01). Median door-to-needle times for patients that re-
ceived IVT were slightly longer for transferred patients (26 
versus 24 minutes; P=0.02). Although the interval from 
Figure 1. Map of the Netherlands including primary 
stroke centers, intervention centers, and population 
density.
Figure 2. Flowchart of patient selection. EVT indicates endovascular 
treatment.
D
ow
nloaded from
 http://ahajournals.org by on July 11, 2019
926  Stroke  April 2019
arrival at the intervention center to start of treatment was 
shorter for transferred patients (47 versus 104 minutes; 
P<0.01, adjusted difference −58 minutes [95% CI, −62 to 
−54]), the total time from onset to groin puncture was still 
substantially longer in these patients (230 versus 170 min-
utes; P<0.01, adjusted difference 40 minutes [95% CI, 31 
to 48]). The median duration of the endovascular procedure 
was similar in both groups (63 versus 62 minutes; P=0.79).
Clinical Outcome
There was a significant shift towards worse functional outcome 
in transferred patients (adjusted common odds ratio [OR] 0.75 
[95% CI, 0.62–0.90]; Figure 3). Transferred patients less 
often achieved functional independence when compared with 
directly admitted patients (mRS 0–2, 33.9% versus 42.4%; 
absolute risk difference −8.5% [95% CI, −8.7 to −8.3]), also 
after (adjustment OR, 0.69 [95% CI, 0.54–0.89]; Tables 3 and 
Table 1. Baseline Characteristics
Direct Presentation, 
n=705
Transferred Patients, 
n=821 P Value
Age, median (IQR) 70 (59–79) 71 (60–80) 0.45
Male sex, n (%) 371/705 (52.6) 438/821 (53.3) 0.78
Baseline NIHSS,* median (IQR) 16 (11–20) 16 (12–20) 0.19
Systolic blood pressure,† mean+SD 149±25 150±25 0.41
Treatment with IVT, n (%) 511/704 (72.6) 659/819 (80.5) <0.01
Presentation outside office hours, n (%) 441/705 (62.6) 541/821 (65.9) 0.17
General anesthesia, n (%) 180/662 (27.2) 205/759 (27.0) 0.94
Medical history
Ischemic stroke, n (%) 118/703 (16.8) 135/814 (16.6) 0.92
Myocardial infarction, n (%) 113/697 (16.2) 120/798 (15.0) 0.53
Diabetes mellitus, n (%) 126/700 (18.0) 136/817 (16.6) 0.49
Atrial fibrillation, n (%) 147/697 (21.1) 188/807 (23.3) 0.31
Prestroke mRS, n (%) 0.02
  0 444/699 (63.5) 573/800 (71.6)  
  1 97/699 (13.9) 98/800 (12.3)  
  2 66/699 (9.4) 49/800 (6.1)  
  ≥3 92/699 (13.2) 80/800 (10.0)  
Imaging characteristics
ASPECTS on first NCCT,‡ median (IQR) 9 (7–10) 8 (7–10) 0.01
Collateral score on first CTA, n (%) <0.01
  Grade 0 42/674 (6.2) 56/743 (7.5)  
  Grade 1 195/674 (28.9) 272/743 (36.6)  
  Grade 2 259/674 (38.4) 288/743 (38.8)  
  Grade 3 178/674 (26.4) 127/743 (17.1)  
Location of occlusion, n (%) 0.01
  ICA 39/693 (5.6) 46/765 (6.0)  
  ICA-T 142/693 (20.5) 180/765 (23.5)  
  Proximal M1 161/693 (23.2) 210/765 (27.5)  
  Distal M1 231/693 (33.3) 240/765 (31.4)  
  M2 100/693 (14.4) 81/765 (10.6)  
  Other§ 20/693 (2.9) 8/765 (1.0)  
ASPECTS indicates Alberta Stroke Program Early CT Score; CTA, computed tomography angiography; ICA, internal carotid 
artery; ICA-T, internal carotid artery tandem; IVT, intravenous thrombolytics; M1, segment 1 of the middle cerebral artery; 
M2, segment 2 of the middle cerebral artery; mRS, modified Rankin Scale; NCCT, noncontrast computed tomography; and 
NIHSS, National Institutes of Health Stroke Scale.
Number of missing values: *30, †43. ‡67.
§Occlusion in segment 1 or 2 of the anterior cerebral artery (A1, n=3; A2, n=3), segment 3 of the middle cerebral artery 
(M3, n=9), or no occlusion visible (n=13) on CTA after adjudication by the imaging assessment committee.
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4). Mortality rates were not significantly different between the 
2 groups (adjustment OR, 1.27 [95% CI, 0.97–1.66]). There 
were no significant differences in successful reperfusion rate 
(adjustment OR, 1.13 [95% CI, 0.91–1.39]) and occurrence of 
symptomatic intracranial hemorrhage (adjustment OR, 0.87 
[95% CI, 0.56–1.36]).
Discussion
In this large, nationwide cohort study, more than half of the 
patients with AIS treated with EVT were transferred from a 
primary stroke center. These patients had significant longer 
time intervals between first presentation and start of treatment, 
between symptom onset and start of treatment, and a lower 
chance of achieving good functional outcome. Even when we 
accounted for the travel time required to transfer a patient to 
an intervention center, start of treatment was still delayed by 
half an hour in transferred patients compared with patients 
who were directly admitted to an intervention center.
From earlier studies, we know that treatment delay 
translates to a decreased chance of achieving a favorable 
outcome.2 However, because of selection bias and time 
delay associated with informed consent procedures, data 
from randomized trials may not always reflect daily prac-
tice. The STRATIS Registry (Systematic Evaluation of 
Patients Treated With Neurothrombectomy Devices for 
Acute Ischemic Stroke) included 984 patients from a large 
region in the United States of America after the implemen-
tation of EVT as standard care.6 Similar to our study, the 
authors found that transferred patients had longer treatment 
times and worse functional outcomes when compared with 
direct admitted patients. However, their time analyses in-
cluded only patients with successful reperfusion, which is 
not a fair representation of routine clinical practice. Also, 
distances between hospitals in rural areas of the USA are 
much larger than in our region, and time delays in primary 
hospitals—for instance because of initiation of IVT—are 
generally longer in the USA than in the Netherlands.8,11,12 
Results from an earlier small study in a region with short 
distances, including only 1 primary stroke center and 1 inter-
vention center, showed that treatment times were longer for 
transferred patients, and the difference between the 2 groups 
for functional outcome was similar to our study.13
The Netherlands is a small, densely populated country, 
with 82 hospitals that provide 24/7 acute stroke care. 
Approximately 99.8% of the Dutch population has the ability 
to reach an emergency department within 45 minutes.14 Our 
country has short between-center distances. This is empha-
sized by the fact that the mean transfer time was only 23 
minutes, indicating that these results probably reflect the 
acute stroke care logistics in other highly populated regions. 
Table 2. Treatment Times, Presented as Medians With Interquartile Range
Direct Presentation, 
n=705
Transferred Patients, 
n=821 P Value
Missing Values, 
n (%)
Onset to door first hospital 55 (37–105) 50 (35–80) <0.01 197/1526 (12.9)
Onset to door intervention center 55 (37–105) 174 (139–220) <0.01 30/1526 (2.0)
Onset to IVT 82 (63–125) 79 (60–115) <0.01 218/1173 (18.6)
Door to needle 24 (18–34) 26 (20–36) 0.02 215/1173 (18.3)
Door to door* N/A 112 (91–140) N/A 196/822 (23.5)
Primary stroke center to intervention center (estimated) N/A 21 (15–31) N/A 3/821 (0.4)
Door in door out† (estimated) N/A 88 (68–117) N/A 197/821 (24.0)
Door first hospital to groin puncture 104 (80–135) 164 (135–198) <0.01 197/1526 (12.9)
Door intervention center to groin puncture 104 (80–135) 47 (31–70) <0.01 30/1526 (2.0)
Onset to groin puncture 170 (135–246) 230 (190–277) <0.01 0
Duration of procedure 62 (40–90) 63 (40–87) 0.79 163/1526 (10.7)
Onset to reperfusion 238 (185–314) 288 (244–343) <0.01 91/1526 (6.0)
IVT indicates intravenous thrombolytics; and N/A, not applicable.
*Door primary stroke center to door intervention center.
†Door to door time minus the estimated travel time from primary stroke center to intervention center.
Table 3. Outcome Measures: Time Intervals
Time Intervals in Minutes
Direct Presentation, 
n=705
Transferred 
Patients, n=821
Unadjusted β (95% 
CI)
Adjusted β* 
(95% CI)
Door first hospital to groin puncture 104 (80 to 135) 164 (135 to 198) 55 (50 to 61) 57 (51 to 62)
Door intervention center to groin puncture 104 (80 to 135) 47 (31 to 70) −59 (−63 to −55) −58 (−62 to −54)
Onset to groin puncture 170 (135 to 246) 230 (190 to 277) 36 (27to 44) 40 (31 to 48)
*Adjusted for age, baseline National Institutes of Health Stroke Severity score, prestroke mRS, treatment with intravenous thrombolytics, 
hypertension (baseline systolic blood pressure >185 mm Hg and diastolic blood pressure >110 mm Hg), location of occlusion, Alberta 
Stroke Program Early CT Score, collateral score, use of general anesthesia, and admission outside office hours.
D
ow
nloaded from
 http://ahajournals.org by on July 11, 2019
928  Stroke  April 2019
Although the observed in-hospital workflow times in this 
study were almost an hour shorter than in the MR-CLEAN 
trial in the Netherlands,15 there is still room for improvement. 
It has been suggested that increased experience, reflected in 
higher volumes of patients treated with EVT, leads to shorter 
treatment times and, subsequently, improved functional out-
comes.16 Workflow times in our cohort do gradually decrease 
over time from 2014 until 2016. A decline in the median 
door-to-groin time (with the door of the first hospital as start) 
was observed for both transfer patients (187–149 minutes) 
and direct patients (123–97 minutes). However, the times 
achieved in our cohort are still longer when compared with 
other studies reporting workflow times. Additional interven-
tions to optimize patient transfer management (eg, holding the 
initial ambulance primary stroke center until the decision of 
EVT eligibility has been made, streamlining transfer proto-
cols, improving cloud-based image sharing, and transporting 
transfer patients directly to the angiosuite) might be useful to 
further reduce transfer-related delay in the future.17–20
Prehospital transportation of stroke patients suspected 
of LVO directly to an intervention center decreases time to 
EVT, but the potential harm of delaying IVT should be taken 
into account as well. We know, however, that the chance of 
achieving recanalization with IVT before thrombectomy in 
patients with LVO is low.21 Therefore, we should focus on 
finding an algorithm to predict LVO early, so that emergency 
medical services can present these patients directly to the in-
tervention center.22,23 Implementing such a triage protocol has 
already shown to be feasible and seems to improve treatment 
times.24 One ongoing randomized trial in Catalonia, Spain, is 
evaluating the effect of the mothership versus the drip-and-
ship strategy on functional outcome, among patients with a 
high likelihood of having a LVO identified with the RACE 
score (RACECAT [Direct Transfer to an Endovascular Center 
Compared to Transfer to the Closest Stroke Centre in Acute 
Stroke Patients With Suspected Large Vessel Occlusion], 
URL: https://www.clinicaltrials.gov. Unique identifier: 
NCT02795962). Although this trial will provide class I ev-
idence on whether a mothership model improves functional 
outcome, it will be challenging to translate its results to re-
gions with other geographic and demographic conditions. 
Modeling studies showed that differences in transportation 
times and treatment times affect the optimal transporta-
tion strategy and that triage protocols should, therefore, be 
based on regional characteristics and individual likelihood of 
LVO.25–28
There were a number of baseline imbalances between 
the 2 groups. First, transferred patients more often received 
Figure 3. Functional outcome measured with the modified Rankin Scale score at 90 days. Functional outcome for patients presented directly in intervention 
center vs transferred from a primary stroke center (125 missing values). Transferred patients had worse functional outcomes than directly presented patients 
(adjusted common odds ratio [acOR] 0.75 [95% CI, 0.62–0.90]).
Table 4. Outcome Measures: Clinical Outcomes
Clinical outcomes
Direct presentation, 
n=705
Transferred 
patients, n=821
Unadjusted OR, 
(95% CI)
Adjusted OR,*  
(95% CI)
Functional independence at 90 days 
(mRS score of 0–2)
289/681 (42.4) 244/720 (33.9) 0.71 (0.58 to 0.88) 0.69 (0.54 to 0.89)
Mortality at 90 days 180/681 (26.4) 227/720 (31.5) 1.24 (0.99 to 1.55) 1.27 (0.97 to 1.66)
Successful reperfusion (eTICI ≥2B) 395/698 (56.6) 473/806 (58.7) 1.10 (0.90 to 1.35) 1.13 (0.91 to 1.39)
Symptomatic ICH 45/705 (6.4) 44/821 (5.4) 0.83 (0.54 to 1.27) 0.87 (0.56 to 1.36)
eTICI, extended Thrombolysis in Cerebral Infarction scale; ICH, intracerebral hemorrhage; and mRS, modified Rankin Scale.
*Adjusted for age, baseline National Institutes of Health Stroke Severity score, prestroke mRS, history of ischemic stroke, 
treatment with intravenous thrombolytics, location of occlusion, Alberta Stroke Program Early CT Score, collateral score, and time 
from onset to first hospital.
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IVT. One of the reasons that could explain this observation is 
that patients who passed the time window for IVT are prob-
ably more often directly transported to an intervention center. 
Second, transferred patients more often had proximal occlu-
sions (ie, ICA, ICA-T, and proximal M1) when compared 
with directly admitted patients. It could be that physicians 
hesitate to transport a patient with a more distal occlusion 
towards the intervention center, as earlier studies showed that 
these occlusions generally respond well to IVT.29 Another ob-
servation that might be explained by a selection mechanism 
in the intervention center is that transferred patients less often 
had prestroke disability. This suggests that patients with favor-
able characteristics are more likely to be transferred to an in-
tervention center. However, imaging characteristics, assessed 
at the hospital of first presentation, were slightly less favorable 
for transferred patients. After adjustment for these baseline 
imbalances, we still found an 8.5% decrease in the chance of 
achieving functional independence after interhospital transfer.
Strengths of our study include that the analyses were 
performed with data from one of the largest cohorts of con-
secutive patients treated with EVT, with individual patient 
data from all stroke intervention centers in the Netherlands. 
It strongly reflects daily clinical practice, including a rel-
atively large number of transferred patients. A number of 
limitations also warrant comment. Despite the fact that the 
MR-CLEAN Registry is a nationwide study with consecu-
tive inclusion of patients, our study is not completely free 
from a risk of selection bias. Patients with an LVO who did 
not receive EVT, for example, due to clinical improvement 
on arrival, were not included in the study. Some patients 
who were initially admitted to a primary stroke center may 
not have been transferred to an intervention center because 
the time window would have been passed by the moment 
they would arrive in the intervention center or because 
there was uncertainty about treatment eligibility in case of 
an M2 occlusion. These patients could have been treated 
if they had been transported directly to the intervention 
center. Since the MR-CLEAN Registry only contains data 
of patients who actually received EVT, we cannot estimate 
the size and impact of this patient population. The negative 
effect of a drip-and-ship strategy might, therefore, be larger 
in real life. Another limitation of our study is that we had 
no recorded door in door out times available to distinguish 
between in-hospital delay in the primary stroke center and 
delay because of the actual travel time between the primary 
stroke center and intervention center. We estimated the av-
erage interhospital travel times using the TomTom MyDrive 
application and then calculated the estimated door in door 
out times. Also, we used multiple imputation for time from 
first presentation to groin puncture, since time of arrival in 
the first hospital was missing for 13% of the patients. The 
difference between transferred patients and directly admit-
ted patients in time from first presentation to groin puncture 
was comparable with the difference in time from onset to 
groin puncture, a variable that was available for all patients. 
We, therefore, believe that it has little impact on the validity 
of our results. Last, even though we adjusted for differences 
in prognostic factors, residual confounding might still influ-
ence our results.
Conclusions
In conclusion, these results from a large national cohort show 
that interhospital transfer of ischemic stroke patients eligible 
for EVT is associated with longer treatment times and worse 
functional outcome in clinical practice, even in a country 
where between-center distances are short. Direct transporta-
tion of EVT candidates to an intervention center might reduce 
treatment delay and thereby may improve functional outcome.
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